Last reviewed · How we verify
Intracoronary injection of stem cell
Intracoronary injection of stem cell is a Biologic drug developed by SCARM Institute, Tabriz, Iran. It is currently in Phase 1 development.
At a glance
| Generic name | Intracoronary injection of stem cell |
|---|---|
| Sponsor | SCARM Institute, Tabriz, Iran |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial (PHASE2)
- Co-transplantation of Mesenchymal Stem Cell Derived Exosomes and Autologous Mitochondria for Patients Candidate for CABG Surgery (PHASE1, PHASE2)
- Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions (PHASE1)
- Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single Ventricle Physiology (PHASE1)
- ICMNC-HF. IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients (PHASE1, PHASE2)
- Bone Marrow Derived Adult Stem Cells for Acute Anterior Myocardial Infarction (NA)
- Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI (PHASE3)
- Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intracoronary injection of stem cell CI brief — competitive landscape report
- Intracoronary injection of stem cell updates RSS · CI watch RSS
- SCARM Institute, Tabriz, Iran portfolio CI
Frequently asked questions about Intracoronary injection of stem cell
What is Intracoronary injection of stem cell?
Intracoronary injection of stem cell is a Biologic drug developed by SCARM Institute, Tabriz, Iran.
Who makes Intracoronary injection of stem cell?
Intracoronary injection of stem cell is developed by SCARM Institute, Tabriz, Iran (see full SCARM Institute, Tabriz, Iran pipeline at /company/scarm-institute-tabriz-iran).
What development phase is Intracoronary injection of stem cell in?
Intracoronary injection of stem cell is in Phase 1.